Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
INNOVUS PHARMACEUTICALS, INC.Listing unverified | AwardD (derivative) | $130K | Unusual size | SEC | |
INNOVUS PHARMACEUTICALS, INC.Listing unverified | AwardD (derivative) | $90K | SEC | ||
INNOVUS PHARMACEUTICALS, INC.Listing unverified | Buy | $490 | conv 89First in 12mo | SEC | |
INNOVUS PHARMACEUTICALS, INC.Listing unverified | Buy | $499 | conv 72First in 12mo | SEC | |
INNOVUS PHARMACEUTICALS, INC.Listing unverified | Buy | $200 | conv 54First in 12mo | SEC | |
INNOVUS PHARMACEUTICALS, INC.Listing unverified | Buy | $499 | conv 82First in 12mo | SEC | |
SEELOS THERAPEUTICS, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SEELOS THERAPEUTICS, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SEELOS THERAPEUTICS, INC.Listing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |